Pharmaceutical Executive December 2, 2021
Danny Flamberg

The adoption and growth of social media for healthcare providers (HCPs) will continue apace in 2022. Social behaviors initially prompted by COVID-19 have become standard operating procedures. Embracing nuances and developing new approaches will distinguish effective competitors from also-rans. For pharma marketers, discerning effectiveness of social media marketing and convincing or finessing conservative medical-legal reviewers will continue to be primary challenges.

Looking ahead, consider these 12 emerging factors:

Investigate Influencers. Self-appointed digital opinion leaders are drawing significant numbers of HCPs into surprisingly detailed scientific and clinical interactive conversations on both public and private social media platforms. Initiated in the scramble to treat COVID-19, the availability of peer-to-peer engagement continues to intrigue and attract generalists and specialists. Pharma marketers are watching...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Provider, Social Media, Technology, Trends
Listening to TikTok — Patient Voices, Bias, and the Medical Record
Trump's new tech era: AI, crypto, social media divide and deals galore
Why some physicians oppose the TikTok ban
Hospitals must fight misinformation, and see it as a threat to their business
Senior Living Operators Stick With Tried-and-True Social Media Strategies Despite Shifting Landscape

Share This Article